Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
A prognostic nomogram based on least absolute shrinkage and selection operator Cox regression in patients with pulmonary large-cell neuroendocrine carcinoma68
LncRNA RP11-10E18.7 cooperates with lncRNA RP11-481C4.2 to affect the overall survival of breast cancer patients: a TCGA-based retrospective study60
Advanced non-small cell lung cancer treated with palliative systemic therapy complicated by calvarial metastasis: a case report42
Molecular basis of heterogeneity in small cell lung cancer33
First-line therapy for recurrent metastatic head and neck squamous cell carcinoma: every rose has its thorn32
Efficacy of second- and third-line chemotherapy after chemotherapy with platinum doublet and immunotherapy in non-small cell lung cancer: a descriptive study31
Efficacy, safety and pharmacokinetics of apatinib plus etoposide versus apatinib alone for platinum-resistant recurrent ovarian cancer: protocol of a multicenter, open-label, randomized phase 2 trial25
Genome-wide profiling of a prognostic RNA-binding protein signature in esophageal cancer24
The efficacy and safety of apatinib in patients with heavily pretreated end-stage cancer: a retrospective study23
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors22
Key considerations for interpreting patient-reported outcomes in deep inferior epigastric artery perforator flap reconstruction with post-mastectomy radiotherapy20
Construction of molecular subtypes and prognostic model for breast cancer based on sulfur metabolism-related genes20
Identification of neuronal synapse-related signatures and potential therapeutic drugs in colorectal cancer based on machine learning algorithms and molecular docking20
Unveiling prognostic factors and predictive modeling in lung adenocarcinoma with neuroendocrine differentiation19
Does circulating DNA tumor fraction add value to prostate-specific antigen in metastatic castration-resistant prostate cancer?19
Development and validation of a prognosis model for patients with brain-metastasis non-small cell lung cancer by machine-learning18
Gastric cancer prognosis: unveiling autophagy-related signatures and immune infiltrates18
Adagrasib in the treatment of KRASG12C-mutated non-small cell lung cancer: a cost-effectiveness analysis17
Effects of p-cresol, a uremic toxin, on cancer cells17
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis17
Clinicopathological characteristics and long-term prognosis of duodenal signet ring cell carcinoma: a SEER-based analysis17
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma17
0.078787088394165